FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200375251> ?p ?o ?g. }

• W4200375251 abstract "Clinical response predictions through image examinations after neoadjuvant chemotherapy (NAC) for breast cancer is important. The present study aimed to evaluate the utility of a novel imaging modality, positron-emission tomography/magnetic resonance imaging (PET/MRI), in predicting the pathological complete response (pCR) to NAC in patients with early breast cancer. A total of 74 patients underwent PET/MRI, mammography (MG), including tomosynthesis, and ultrasound (US) after NAC. The complete response was predicted using each modality and these outcomes were compared accordingly. In terms of PET/MRI, complete response (CR) was defined as the disappearance of 18F-fluorodeoxyglucose uptake and the absence of enhanced lesions with contrast enhanced MRI. In MG and US, undetectable lesions were considered as CR. The background and tumor characteristics of patients were also analyzed between the pCR and non-pCR cases. Overall, 18 (24.3%) of the 74 patients achieved pCR. The overall sensitivity and specificity of PET/MRI were 72.2 and 78.6%, respectively. Both the sensitivity in hormone receptor (HR)-positive cases and the specificity in HR-negative cases were 100%. HR-negative and human epidermal growth factor receptor 2 (HER2)-positive cases demonstrated a significant association with pCR compared with HR-positive cases and triple negative cases (P=0.017). Furthermore, patients with 'mass' type lesions evaluated by MRI before NAC experienced pCR with a higher frequency than those with 'non-mass' type lesions. There was a statistically significant difference between the two groups (P=0.018). In conclusion, PET/MRI is a different diagnostic approach that utilizes a multi-modality system. It demonstrates reasonable diagnostic accuracies of the responses of NAC with reference to hormonal subtypes in breast cancer." @default.
• W4200375251 created "2021-12-31" @default.
• W4200375251 creator A5001364171 @default.
• W4200375251 creator A5004481053 @default.
• W4200375251 creator A5023799318 @default.
• W4200375251 creator A5027514691 @default.
• W4200375251 creator A5037108461 @default.
• W4200375251 creator A5047638458 @default.
• W4200375251 creator A5054369256 @default.
• W4200375251 creator A5059857726 @default.
• W4200375251 creator A5064222460 @default.
• W4200375251 creator A5075853905 @default.
• W4200375251 creator A5082213801 @default.
• W4200375251 creator A5083345024 @default.
• W4200375251 creator A5084679633 @default.
• W4200375251 date "2021-12-24" @default.
• W4200375251 modified "2023-10-13" @default.
• W4200375251 title "Preliminary experiences of PET/MRI in predicting complete response in patients with breast cancer treated with neoadjuvant chemotherapy" @default.
• W4200375251 cites W1708330578 @default.
• W4200375251 cites W1967594797 @default.
• W4200375251 cites W1979313251 @default.
• W4200375251 cites W1988673436 @default.
• W4200375251 cites W2011126574 @default.
• W4200375251 cites W2017098623 @default.
• W4200375251 cites W2039467152 @default.
• W4200375251 cites W2048645725 @default.
• W4200375251 cites W2054968380 @default.
• W4200375251 cites W2065000080 @default.
• W4200375251 cites W2071724782 @default.
• W4200375251 cites W2091591262 @default.
• W4200375251 cites W2096145980 @default.
• W4200375251 cites W2097313333 @default.
• W4200375251 cites W2113242459 @default.
• W4200375251 cites W2127650183 @default.
• W4200375251 cites W2132472435 @default.
• W4200375251 cites W2139873365 @default.
• W4200375251 cites W2147411421 @default.
• W4200375251 cites W2150539933 @default.
• W4200375251 cites W2166457180 @default.
• W4200375251 cites W2261392913 @default.
• W4200375251 cites W2320000291 @default.
• W4200375251 cites W2509398808 @default.
• W4200375251 cites W2531510527 @default.
• W4200375251 cites W2572933046 @default.
• W4200375251 cites W2585229356 @default.
• W4200375251 cites W2588061738 @default.
• W4200375251 cites W2618058692 @default.
• W4200375251 cites W2758722960 @default.
• W4200375251 cites W2802542721 @default.
• W4200375251 cites W4378626674 @default.
• W4200375251 doi "https://doi.org/10.3892/mco.2021.2483" @default.
• W4200375251 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35070299" @default.
• W4200375251 hasPublicationYear "2021" @default.
• W4200375251 type Work @default.
• W4200375251 citedByCount "4" @default.
• W4200375251 countsByYear W42003752512022 @default.
• W4200375251 countsByYear W42003752512023 @default.
• W4200375251 crossrefType "journal-article" @default.
• W4200375251 hasAuthorship W4200375251A5001364171 @default.
• W4200375251 hasAuthorship W4200375251A5004481053 @default.
• W4200375251 hasAuthorship W4200375251A5023799318 @default.
• W4200375251 hasAuthorship W4200375251A5027514691 @default.
• W4200375251 hasAuthorship W4200375251A5037108461 @default.
• W4200375251 hasAuthorship W4200375251A5047638458 @default.
• W4200375251 hasAuthorship W4200375251A5054369256 @default.
• W4200375251 hasAuthorship W4200375251A5059857726 @default.
• W4200375251 hasAuthorship W4200375251A5064222460 @default.
• W4200375251 hasAuthorship W4200375251A5075853905 @default.
• W4200375251 hasAuthorship W4200375251A5082213801 @default.
• W4200375251 hasAuthorship W4200375251A5083345024 @default.
• W4200375251 hasAuthorship W4200375251A5084679633 @default.
• W4200375251 hasBestOaLocation W42003752512 @default.
• W4200375251 hasConcept C121608353 @default.
• W4200375251 hasConcept C126322002 @default.
• W4200375251 hasConcept C126838900 @default.
• W4200375251 hasConcept C143409427 @default.
• W4200375251 hasConcept C207886595 @default.
• W4200375251 hasConcept C2775842073 @default.
• W4200375251 hasConcept C2776694085 @default.
• W4200375251 hasConcept C2780472235 @default.
• W4200375251 hasConcept C2989005 @default.
• W4200375251 hasConcept C530470458 @default.
• W4200375251 hasConcept C71924100 @default.
• W4200375251 hasConceptScore W4200375251C121608353 @default.
• W4200375251 hasConceptScore W4200375251C126322002 @default.
• W4200375251 hasConceptScore W4200375251C126838900 @default.
• W4200375251 hasConceptScore W4200375251C143409427 @default.
• W4200375251 hasConceptScore W4200375251C207886595 @default.
• W4200375251 hasConceptScore W4200375251C2775842073 @default.
• W4200375251 hasConceptScore W4200375251C2776694085 @default.
• W4200375251 hasConceptScore W4200375251C2780472235 @default.
• W4200375251 hasConceptScore W4200375251C2989005 @default.
• W4200375251 hasConceptScore W4200375251C530470458 @default.
• W4200375251 hasConceptScore W4200375251C71924100 @default.
• W4200375251 hasIssue "2" @default.
• W4200375251 hasLocation W42003752511 @default.
• W4200375251 hasLocation W42003752512 @default.
• W4200375251 hasLocation W42003752513 @default.
• W4200375251 hasOpenAccess W4200375251 @default.
• W4200375251 hasPrimaryLocation W42003752511 @default.

• next